Optimizing Strategies And Technologies For Decentralized And Hybrid Clinical Trials

Clinical trial protocols in the modern era involve more sites, participants, and data points than ever. As a result, study protocols have become more complex, putting patients and sites at a greater risk of burdens. While clinical trials can benefit from decentralized strategies and technologies, ill-conceived implementation of these elements, particularly from a technology standpoint, can increase obligations on the site, patients, and sponsors.

The need for advanced protocol development must consider how technologies intersect with patient visits and data collection as the industry has more widely adopted decentralized strategies and technologies. This requires specialized insight into each patient population, the scientific expertise to focus the protocol on the most critical research questions that meet regulatory requirements, and data science experts who can optimize technology to drive better outcomes and deliver cleaner data. Ideally, protocol considerations and technology implementation begin in parallel, but often that is not the case.

This e-book examines several considerations that should be taken when selecting a technology platform that can create operational efficiencies, reduce site burdens, and ensure accurate data collection throughout a clinical trial.